UBIVAC, INC.
PORTLAND, OR · CIK 0001713945 · Biotech · Private
DPV-001, a therapeutic cancer vaccine combining personalized neoantigen identification with immunotherapy
ubivac.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $1.5M
- 7 Form D · Aug 2026
- 2 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $200,000 | |
| Private capital raised | Form D · SEC | $800,000 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $50,000 | |
| Private capital raised | Form D · SEC | $35,000 | |
| Private capital raised | Form D · SEC | $80,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1471 | CALIFORNIA STEM CELL INC | — | $1.9M |
| 1472 | Aptorum Group Ltd | — | $1.6M |
| 1473 | RESBIOTIC, INC. | — | $1.6M |
| 1474 | UBIVAC, INC. | — | $1.5M |
| 1475 | EXSCIEN CORPORATION | — | — |
| 1476 | SirnaMed Therapeutics Inc. | — | $1.3M |
| 1477 | AstralBio, Inc. | — | $957K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Steve BuhalyExecutive Officer
- Bernard A. Fox, IIIExecutive Officer
- Bernard Fox III, MBAExecutive Officer
- Bernard Fox, MBAExecutive Officer
- Bernard Fox, Ph.DDirector · Executive Officer
- Bernard Fox, Ph.D.Director · Executive Officer
- Hong-Ming Hu, Ph.DDirector · Executive Officer
- Hong-Ming Hu, Ph.D.Director · Executive Officer
- Nancy LimeExecutive Officer
- Sung Poblete, R.N., Ph.D.Director
- Jon Wigginton, M.D.Director
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.